Carbendazim inhibits cancer cell proliferation by suppressing microtubule dynamics

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 2, 2009, Pages 390-398

  Yenjerla, Mythili ^a   Cox, Corey ^a   Wilson, Leslie ^a   Jordan, Mary Ann ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBENDAZIM; CHLORPHENOTANE; COLCHICINE; FUNGICIDE; PROTEIN P53; TUBULIN; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG BINDING SITE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; PRIORITY JOURNAL;

BENZIMIDAZOLES; BREAST NEOPLASMS; CARBAMATES; CELL LINE, TUMOR; CELL PROLIFERATION; COLCHICINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROTUBULES; MITOSIS; TUBULIN;

EID: 59649117610     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.143537     Document Type: Article

References (37)

1. Aneja R, Lopus M, Zhou J, Vangapandu SN, Ghaleb A, Yao J, Nettles JH, Zhou B, Gupta M, Panda D, Chandra R, and Joshi HC (2006) Rational design of the microtubule-targeting anti-breast cancer drug EM015. Cancer Res 66:3782-3791.
2. Bhattacharyya B and Wolff J (1975) The interaction of 1-anilino-8-naphthalene sulfonate with tubulin: a site independent of the colchicine-binding site. Arch Biochem Biophys 167:264-269.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Brand L and Gohlke JR (1972) Fluorescence probes for structure. Annu Rev Biochem 41:843-868.
5. Can A and Albertini DF (1997) M-phase specific centrosome-microtubule alterations induced by the fungicide MBC in human granulosa cells. Mutat Res 373:139-151.
6. Davidse LC (1986) Benzimidazole fungicides: mechanism of action and biological impact. Annu Rev Phytopathol 24:43-65.
7. Davidse LC and Flach W (1977). Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans. J Cell Biol 72:174-193.
8. Downing KH (2000) Structural basis for the action of drugs that affect microtubule dynamics. Expert Opin Ther Targets 4:219-237.
9. Friedman PA and Platzer EG (1978) Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulin. Biochim Biophys Acta 544:605-614.
10. Friedman PA and Platzer EG (1980) Interaction of anthelmintic benzimidazoles with Ascaris suum embryonic tubulin. Biochim Biophys Acta 630:271-278.
11. Gupta K, Bishop J, Peck A, Brown J, Wilson L, and Panda D (2004) Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. Biochemistry 43:6645-6655.
12. Hamel E (1996) Antimitotic natural products and their interactions with tubulin. Med Res Rev 16:207-231.
13. Hammond LA, Davidson K, Lawrence R, Camden JB, Von Hoff DD, Weitman S, and Izbicka E (2001) Exploring the mechanisms of action of FB642 at the cellular level. J Cancer Res Clin Oncol 127:301-313.
14. Hao D, Rizzo JD, Stringer S, Moore RV, Marty J, Dexter DL, Mangold GL, Camden JB, Von Hoff DD, and Weitman SD (2002) Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642). Invest New Drugs 20:261-270.
15. Jordan MA and Kamath K (2007) How do microtubule-targeted drugs work? An overview. Curr Cancer Drug Targets 7:730-742.
16. Jordan MA and Wilson L (1998) Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 10:123-130.
17. Jordan MA and Wilson L (2008) Microtubule dynamics: Mechanisms and regulation by microtubule-associated proteins and drugs in vitro and in cells, in The Role of Microtubules in Cell Biology, Neurobiology, and Oncology (Fojo T ed) pp 47-81, Humana Press, Totowa, NJ.
18. Jordan MA, Kamath K, Manna T, Okouneva T, Miller HP, Davis C, Littlefield BA, and Wilson L (2005) The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth. Mol Cancer Ther 4:1086-1095.
19. Jordan MA, Walker D, de Arruda M, Barlozzari T, and Panda D (1998) Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action. Biochemistry 37:17571-17578.
20. Kamath K, Okouneva T, Larson G, Panda D, Wilson L, and Jordan MA (2006) 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules. Mol Cancer Ther 5:2225-2233.
21. Kelling J, Sullivan K, Wilson L, and Jordan MA (2003) Suppression of centromere dynamics by Taxol in living osteosarcoma cells. Cancer Res 63:2794-2801.
22. Lacey E and Watson TR (1985). Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin, in vitro. Biochem Pharmacol 34:1073-1077
23. Luduena RF (1979) Biochemistry of tubulin, in Microtubules (Robert K and Hyams J eds) pp 94-95, Academic Press, New York.
24. McIntosh JR, Grishchuk EL, and West RR (2002) Chromosome-microtubule interactions during mitosis. Annu Rev Cell Dev Biol 18:193-219.
25. Mitchison T and Kirschner M (1984). Dynamic instability of microtubule growth. Nature 312:237-242.
26. Nicklas RB (1997) How cells get the right chromosomes. Science 275:632-637.
27. Okouneva T, Azarenko O, Wilson L, Littlefield BA, and Jordan MA (2008) Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase. Mol Cancer Ther 7:2003-2011.
28. Okouneva T, Hill BT, Wilson L, and Jordan MA (2003) The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol Cancer Ther 2:427-436.
29. Panda D, Miller HP, and Wilson L (1999) Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau. Proc Natl Acad Sci U S A 96:12459-12464.
30. Pfeffer TA, Asnes CF, and Wilson L (1976) Properties of tubulin in unfertilized sea urchin eggs: quantitation and characterization by the colchicine-binding reaction. J Cell Biol 69:599-607.
31. Richards KL, Anders KR, Nogales E, Schwartz K, Downing KH, and Botstein D (2000) Structure-function relationships in yeast tubulins. Mol Biol Cell 11:1887-1903.
32. Shelby RD, Hahn KM, and Sullivan KF (1996) Dynamic elastic behavior of alpha-satellite DNA domains visualized in situ in living human cells. J Cell Biol 135:545-557.
33. Skibbens RV, Skeen VP, and Salmon ED (1993) Directional instability of kinetochore motility during chromosome congression and segregation in mitotic newt lung cells: a push-pull mechanism. J Cell Biol 122:859-875.
34. Waters JC, Skibbens RV, and Salmon ED (1996) Oscillating mitotic newt lung cell kinetochores are, on average, under tension and rarely push. J Cell Sci 109:2823-2831.
35. Weisenberg RC, Borisy GG, and Taylor EW (1968) The colchicine-binding protein of mammalian brain and its relation to microtubules. Biochemistry 7:4466-4479.
36. Wilson L and Bryan J (1974) Biochemical and pharmacological properties of microtubules. Adv Cell Mol Biol 3:21-72.
37. Winder BS, Strandgaard CS, and Miller MG (2001) The role of GTP binding and microtubule-associated proteins in the inhibition of microtubule assembly by carbendazim. Toxicol Sci 59:138-146.